Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's Disease

1 Mar 2007

Abstract excerpt

Excitatory neurotransmitter dysfunction has been discussed to be involved in the pathophysiology of Alzheimer's disease (AD). In the current study we investigated gene and protein expression patterns of glutamatergic receptors and transporters in brains of AD patients in various stages of disease using gene chip arrays, real time PCR and immunohistochemistry. We found marked impairment in the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to GABA and Rice Research
Share to Neuroscience and Neuropharmacology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17361039
DOI: 10.3233/jad-2007-11113

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alterations in Expression of Glutamatergic Transporters and Receptors in Sporadic Alzheimer's DiseasePMID 17361039Read ↗

Age and Alzheimer’s disease gene expression profiles reversed by the glutamate modulator riluzoleSemantic proximity Read ↗

The role of metabotropic glutamate receptors in Alzheimer's diseaseSemantic proximity Read ↗

Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer’s Disease, a Potential Therapeutic TargetSemantic proximity Read ↗

Expression of SLC25A18 is positively correlated with Alzheimer's diseaseSemantic proximity Read ↗

Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer’s DiseaseSemantic proximity Read ↗

Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein.Semantic proximity Read ↗

Sexual Dimorphism, Altered Hippocampal Glutamatergic Neurotransmission and Cognitive Impairment in APP Knock-In MiceSemantic proximity Read ↗

Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric diseaseSemantic proximity Read ↗

Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer's diseaseSemantic proximity Read ↗

Targeting N‐methyl‐D‐aspartate Receptors in Neurodegenerative DiseasesSemantic proximity Read ↗

The Q/R editing site of AMPA receptor GluA2 subunit acts as an epigenetic switch regulating dendritic spines, neurodegeneration and cognitive deficits in Alzheimer’s diseaseSemantic proximity Read ↗

An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.